Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Carmela Pera

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Frontiers in Neurology|July 2, 2026
Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophyGiorgia Coratti, Chiara Bravetti, Gianpaolo Cicala, et al.
Neurology. Clinical Practice|June 27, 2024
Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3Federica Trucco, Deborah Ridout, Harriet Weststrate, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 30, 2026
Loss of ambulation in SMA III at the time of disease-modifying treatments: an international studyGiorgia Coratti, Francesca Bovis, Valentina Franchino, et al.
Annals of Neurology|September 14, 2020
Clinical Variability in Spinal Muscular Atrophy Type IIIGiorgia Coratti, Sonia Messina, Simona Lucibello, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Frontiers in Neurology|July 2, 2026
Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophyGiorgia Coratti, Chiara Bravetti, Gianpaolo Cicala, et al.
Neurology. Clinical Practice|June 27, 2024
Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3Federica Trucco, Deborah Ridout, Harriet Weststrate, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 30, 2026
Loss of ambulation in SMA III at the time of disease-modifying treatments: an international studyGiorgia Coratti, Francesca Bovis, Valentina Franchino, et al.
Annals of Neurology|September 14, 2020
Clinical Variability in Spinal Muscular Atrophy Type IIIGiorgia Coratti, Sonia Messina, Simona Lucibello, et al.
Pageof 9